DIN 02490536 — NERLYNX 40 MG
NERLYNX is a tablet of Neratinib marketed by KNIGHT THERAPEUTICS INC.. The full Neratinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02490536
- Brand name
- NERLYNX
- Active ingredient
- Neratinib
- Strength
- 40 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- KNIGHT THERAPEUTICS INC.
- Health Canada status
- MARKETED
- Drug class
- Pan-HER tyrosine kinase inhibitor (antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.